NASDAQ · STOCK
Aflac
$121.91
52W $96.95 – $122.80
64/100
$58448.61T
13.9
0.60
Price History (6M)
Executive Summary
5 analysts weighed in with 60% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Daily trend: uptrend.
- Weekly trend: uptrend.
- Daily and weekly trends are both bullish — multi-timeframe alignment, highest confidence.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Stochastic RSI (95.4) confirms overbought conditions.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
64/100
Agreement
60%
Analysts
5
Conviction
Moderate
Growth Analyst
neutral
52
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− 2 consecutive earnings misses -- execution concerns
Technical Analyst
bullish
63
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
67.2
Neutral
MACD Histogram
0.313
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Bollinger %B
0.87
Inside Bands
Price vs Moving Averages
EMA 9
$120.65
Above
EMA 21
$119.09
Above
EMA 50
$117.01
Above
EMA 200
$112.48
Above
Fundamental Analysis
Valuation
97
Growth
71
Profitability
1
Financial Health
100
Cash Flow
38
Valuation
P/E Ratio
13.9×
P/B Ratio
2.09×
PEG Ratio
0.38
Dividend Yield
0.02%
52W High
$122.80
52W Low
$96.95
Quality & Growth
ROE
12.4%
ROA
3.1%
Gross Margin
47.8%
Operating Margin
31.0%
Revenue Growth YoY
—
Debt / Equity
0.26
AI Fundamental Assessment
P/E ratio of 13.9 (inexpensive relative to a 15-40x range); Price-to-book of 2.1x; PEG ratio of 0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.0%; Net margin of 0.3%; Gross margin of 0.5%; Current ratio of 8.86 (healthy short-term liquidity); Debt-to-equity of 0.26; Free cash flow margin of 1.0% (thin cash generation); Free cash flow per share is positive (5.72); Most recent quarter missed estimates by 4.4%; 2 consecutive earnings misses; EPS growth accelerating (-36.9% -> +11.5% QoQ); Analyst estimates rising over recent quarters
Key Risks
- Stochastic RSI (95.4) confirms overbought conditions.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full AFL Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile